Press Releases

BioMed X Institute launches Rapid Antiviral Response Platform to prevent future pandemics

BioMed X, an independent research institute that identifies big biomedical research challenges and provides innovative solutions by combining global crowdsourcing with local incubation, announces the launch of its new Rapid Antiviral Response Platform (RAR). In response to the devastating COVID-19...

Thermo Fisher Scientific Response to COVID-19 Expands to Include New Serology Test

Thermo Fisher Scientific Inc., the world leader in serving science, announced it will expand its response to the COVID-19 pandemic by developing a total antibodies test in collaboration with WuXi Diagnostics and Mayo Clinic. The new test is the...

Clariant in India extends support to local communities during COVID-19 times

Clariant, a focused, sustainable and innovative specialty chemical company, has in the past weeks initiated the production of sanitiser solutions from its facilities in India to help curb the spread of COVID-19. Clariant’s sites across Roha, Maharashtra; Bonthapally, Telangana;...

CPhI & P-MEC China to host ‘Virtual Expo Connect’ in June

Co-organized by Informa Markets, CCCMHPIE and Sinoexpo Informa Markets – will host a special Virtual Expo Connect in June (18-24, 2020). The new online platform is designed to facilitate ongoing and new business connections in an age of travel...

Catalent Signs Development Agreement with Ennaid Therapeutics on its COVID-19 Lead Program

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at COVID-19....

Vibalogics announces collaboration to provide additional clinical trial material for covid-19 vaccine candidate

Vibalogics, a global contract development and manufacturing organization (CDMO) that specializes in the production of virotherapy products, announced that it will manufacture additional clinical trial material for the lead COVID-19 vaccine candidate currently in development by the Janssen Pharmaceutical...

Greenphire Enhances Its Participant Payment and Reimbursement Solution to Further Support Remote Clinical Trials

As the COVID-19 pandemic continues to limit movement all over the world, clinical trials have had to adapt by leveraging methodologies typically associated with hybrid or remote clinical trial designs. The alternative would be to suspend the trial and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read